chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Muscles cramped; dizzy; vertigo; A spontaneous report was received from a consumer concerning a 72-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events muscles cramped, spasmed, biting, dizzy, vertigo, couldn't stand.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 3 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 012M20A) intramuscularly for prophylaxis of COVID-19 infection.  On 5 Feb 2021, the patient experienced the event(s) muscles cramped . On 5 Feb 2021, the patient experienced the event(s) spasmed . On 5 Feb 2021, the patient experienced the event(s) biting . On 5 Feb 2021, the patient experienced the event(s) dizzy . On 5 Feb 2021, the patient experienced the event(s) vertigo . On 5 Feb 2021, the patient experienced the event(s) couldn't stand.  Treatment details included Took Tylenol.  Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of event(s), muscles cramped was unknown.The outcome of event(s), spasmed was unknown.The outcome of event(s), biting was unknown.The outcome of event(s), dizzy was unknown.The outcome of event(s), vertigo was unknown.The outcome of event(s), couldn't stand was unknown..
patient received the shot and was walking to a chair to sit down and passed out, he hit his head on the floor, we called 911 and the paramedics took him to the hospital because he still wasn't feeling good. the patient hadn't eaten prior to the vaccine
Had vulvar issues and lesions; Had vulvar issues and lesions; Was diagnosed by biopsy as lichen planus; Diagnosed by biopsy as lichen planus, which had flare up after booster; Had oral lesions; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 50 , in left arm for covid-19 immunisation. The patient's relevant medical history included: "Seasonal allergies" (unspecified if ongoing), notes: Known allergies: Seasonal allergies. Concomitant medication(s) included: ALBUTEROL [SALBUTAMOL]. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left), administration date: 14Jan2021, when the patient was 50-year-old, for COVID-19 immunization, reaction(s): "Had vulvar issues and lesions", "Was diagnosed by biopsy as lichen planus"; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left), administration date: Dec2020, when the patient was 50 years old, for COVID-19 immunization. The following information was reported: LICHEN PLANUS (non-serious) with onset 2021, outcome "not recovered", described as "Diagnosed by biopsy as lichen planus, which had flare up after booster"; ORAL DISORDER (non-serious) with onset 2021, outcome "not recovered", described as "Had oral lesions"; VULVAL DISORDER (non-serious), VULVAL DISORDER (non-serious) all with onset 2021, outcome "not recovered" and all described as "Had vulvar issues and lesions"; LICHEN PLANUS (non-serious) with onset 2021, outcome "not recovered", described as "Was diagnosed by biopsy as lichen planus". The events "had vulvar issues and lesions", "was diagnosed by biopsy as lichen planus", "diagnosed by biopsy as lichen planus, which had flare up after booster" and "had oral lesions" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of vulval disorder, vulval disorder, lichen planus, lichen planus, oral disorder.  Additional information: The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received Multivitamins and Albuterol inhaler prn within 2 weeks of vaccination. It was reported that, the patient had vulvar issues and lesions which was diagnosed by biopsy as lichen planus, which had flare up after booster. After booster, she had oral lesions also for which she visited her dentist and was still getting workup for lichen planus. She was due for the second booster, but worried about flare up. The patient was treated with steroids topical, tacrolimus topical and dental visit was done. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, she had not been tested for COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
2 days Left Ear congestion, 6 days Left Elbow large swelling, 2 days chills, then 2 days chills again a few days later
Localized wheal at site of injection w/pruritus and warmth at right deltoid. No fever, no vomiting. No syncope or dizziness..
Day after vaccine, complained of aching bilateral legs and sore ankles. Ankles red and hot with pain. Still present and improves with ambulation. Denies tremors, nausea, vomiting, diarrhea or fever. (OMIC)
shaking / shaking legs; Pain in arm; headache; pain in the shoulder; chills; nausea; fever (100.5°F); extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking / shaking legs), PAIN IN EXTREMITY (Pain in arm), HEADACHE (headache), ARTHRALGIA (pain in the shoulder) and CHILLS (chills) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced TREMOR (shaking / shaking legs), PAIN IN EXTREMITY (Pain in arm), HEADACHE (headache), ARTHRALGIA (pain in the shoulder), CHILLS (chills), NAUSEA (nausea), PYREXIA (fever (100.5°F)) and FATIGUE (extremely tired). At the time of the report, TREMOR (shaking / shaking legs), PAIN IN EXTREMITY (Pain in arm), HEADACHE (headache), ARTHRALGIA (pain in the shoulder), CHILLS (chills), NAUSEA (nausea), PYREXIA (fever (100.5°F)) and FATIGUE (extremely tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Body temperature: 100.5 (High) 100.5F.         Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Menstrual cycle affected; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 12Jun2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On an unknown date in 2021, the patient's menstrual cycle affected. The clinical outcome of the event menstrual cycle affected was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sore arm; breast hardness and hurting; breast hardness and hurting; swelling on hands and feet; could not move the arm , could not put clothes neither use ring; joint hurting; shoulder cracking; was in bed all day; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Sore arm), BREAST PAIN (breast hardness and hurting), BREAST INDURATION (breast hardness and hurting), PERIPHERAL SWELLING (swelling on hands and feet) and LIMB DISCOMFORT (could not move the arm , could not put clothes neither use ring) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Sore arm), BREAST PAIN (breast hardness and hurting), BREAST INDURATION (breast hardness and hurting), PERIPHERAL SWELLING (swelling on hands and feet), LIMB DISCOMFORT (could not move the arm , could not put clothes neither use ring), ARTHRALGIA (joint hurting), ARTHRALGIA (shoulder cracking), FATIGUE (was in bed all day ) and PYREXIA (Fever). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Sore arm), BREAST PAIN (breast hardness and hurting), BREAST INDURATION (breast hardness and hurting), PERIPHERAL SWELLING (swelling on hands and feet), ARTHRALGIA (joint hurting), ARTHRALGIA (shoulder cracking), FATIGUE (was in bed all day ) and PYREXIA (Fever) outcome was unknown and LIMB DISCOMFORT (could not move the arm , could not put clothes neither use ring) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Event outcome updated.  Patient denied to further follow-up.
Report joint pain after receiving the Moderna COVID-19 vaccination; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Report joint pain after receiving the Moderna COVID-19 vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Report joint pain after receiving the Moderna COVID-19 vaccination). At the time of the report, ARTHRALGIA (Report joint pain after receiving the Moderna COVID-19 vaccination) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-036059 (Patient Link).
The day of my second shot I developed a swollen tongue and concerned about getting the next shot went to the walk in clinic.  I have been taking Lisinopril for over 15 years without a problem. But they diagnosed me with a reaction called angioedema and gave me a epinephrine shot and sent me by ambulance to the Hospital.
ERYTHEMA 3 1/2 X 4 CM LEFT ANTERIOR THIGH, WARM TO TOUCH, NON TENDER AND NO STREAKING.  VACCINE MARK AT TOP LEFT SIDE OF ERYTHEMATOUS PATCH.
Extreme fatigue swollen lymph nodes And a stye/chalazion (I?m fine- reporting in case other people experienced these things as well)
See attached page. Has 13cm x 12cm erythema at pneumovax site, which was administered 10/20/06. MD faxed order for Pneumonia shot.
Mother noticed onset of right thigh lump and redness 1 week after administration of varicella vaccine.
Pt suffered a 45 min sz that had a gradual onset which progressed to unconciousness accompanied by periods of apnea & vomiting; Phenobarbitol used to terminate sz; pt was transferred p/being stabilized, to be observed & treated in PICU;
Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 8/18/21 and 9/08/21. Presented to PCP 1/21/22 with cc of L knee pain, found to be hypoxemic at 80%. Transferred to ED, Covid + (known exposure from wife), admitted to  floor for acute hypoxemic resp failure 2/2 Covid PNA, started on empiric antimicrobial and decadron, same day transferred to ICU for worsening hypoxemia, heparin gtt initiated secondary to presumed PE. 1/23/22m intubated, MRI showed multifocal supratentorial and infratentorial acute infarcts likely of embolic source. Developed a L pneumothorax on 1/30/21. Renal fx continued to worsen. Transitioned to DNAR, expired 2/05/22.
'lymph node' swelling around left clavicle that is painful and she can feel it when she lifts her arm. Swelling hasn't gotten better from Day 1. Negative rash, difficulty breathing, or selling in other areas. Recommended to continue monitoring symptoms and to seek urgent care if any worsening symptoms or other concerning symptoms develop.
Patient seen in clinic the day after 2nd Moderna COVID-19 vaccination for routine follow up.  No side effects except for injection site pain. Routine labs showed low platelet count of 106,000. Prior platelet count 159,000 in 12/2019 Platelets rechecked 3/24 and recovered to 151,000.
15 hours after receiving the second dose, I developed a fever of 100 degrees, chills, headache, muscle aches, and fatigue that lasted for 24 hours -even though I took extra strength tylenol every 6 hours for 36 hours.  In addition to a sore right arm injection site, I developed very large / swollen (the size of an egg) and tender lymph nodes in the right axilla that still persisted even after more than 48 hours since receiving the injection.
S/S-difficulty breathing, wheezing, weakness, increase HR; diaphoresis. Symptoms started at 10pm and lasted for 6.5 hrs. 10/23/02 Lantus insulin 10ml #30 (30 days) inject 100 units at bedtime.
Doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not reported No Adverse events occurred. No temperature excursion was happen. On 04-Nov-2021 vaccine was placed in refrigerator Treatment information was not reported.
Rolling vials between their hands and/or tucking vial into their underarms to thaw the vaccine; This spontaneous case was reported by a nurse and describes the occurrence of WRONG TECHNIQUE IN DEVICE USAGE PROCESS (Rolling vials between their hands and/or tucking vial into their underarms to thaw the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG TECHNIQUE IN DEVICE USAGE PROCESS (Rolling vials between their hands and/or tucking vial into their underarms to thaw the vaccine). At the time of the report, WRONG TECHNIQUE IN DEVICE USAGE PROCESS (Rolling vials between their hands and/or tucking vial into their underarms to thaw the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On an unknown date, the patient was administered an improperly stored PNEUMOVAX 23 (strength, dose and route were not reported, lot # R018735, expiration date 06-APR-2020, therapy type digital data logger) for prophylaxis (product storage error). The vaccines experienced temperature excursion from 32 Fahrenheit degrees to 35 (34.9) Fahrenheit degrees for 1 hour and 30 minutes. There was no previous temperature excursion. No adverse events were reported. A data logger was involved.
Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Nausea.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 24-Jan-2021 and the estimated date of delivery was 31-Oct-2021. On 02-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  ninth week of the pregnancy.  On 02-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Patient received 0.2mL of adult Pfizer instead of pediatric Pfizer, patient is experiencing fever
6 month old received an adult dose; 6 month old received an adult dose; This case was reported by a nurse via call center representative and described the occurrence of overdose in a 6-month-old male patient who received HBV (Engerix B adult) (batch number TB3KN, expiry date 3rd December 2023) for prophylaxis.   On 10th October 2022, the patient received the 3rd dose of Engerix B adult. On 10th October 2022, unknown after receiving Engerix B adult, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown.   Additional Information: GSK Receipt Date: 10-Oct-2022 Reporter's comment: A nurse reported that the patient received an adult 1 ml dose of Engerix. No symptoms were reported.  The reporter consented to follow up. Additional Supportive Information: The 6 months old patient received an adult 1 ml dose of Engerix, which led to overdose and adult product administered to child.
starting about 24 hours after vaccine I began having a sever headache.  I went to bed very early (8 pm) and work multiple times throughout the night.  I had a fever that peaked at 101.2 (SEVERE BODY SHAKING)  could not drink enough to quench my thirst.  I also had severe body and joint aches.  I finally fell asleep again about 4 am, woke at 6 am and felt better.  Fever was gone but body aches have continued as has the headache.  It is now Monday 1:50 pm (about 48 hours after the 2nd COVID vaccine)
My menstrual cycle has been always been regular.  After I recieved the Gardasil vaccine, I did not get my period when I was supposed to.  I took a pregnancy test but it came back negative.  I still have not had my period.  It is now two weeks late.  There are many forums on the internet that describe the same symptoms as me.  Please look into it.  A lot of sexually active women are getting very stressed out because of this unknown side effect of a late or missed period.
PATIENT HAS BEEN OBSERVING RED SPOTS COME UP ALONG HER ARM, IT WOULD APPEAR AND PUSS OVER AND CAUSE A BRUISE. PATIENT DOES SAY IT IS ITCHY, BUT IT'S NOT IN CLUSTERS. AND IT'S ONLY OCCURING ON THE LEFT SIDE OF HER BODY WHERE SHE GOT THE INJECTION.
Fluarix dispensed and administered to newborn in error. Newborn should have received Engerix-B. Products look very similiar-especially when they are removed from outer packaging.
pt recvd vax & 3 dasy later exp itching legs, gluteal; itching lasted for about 1 wk;
Patient had Tetanus toxiod in right deltoid as well as flu and Pneumo in the left deltoid.  Later in the day patient experienced lump in left axilla also pain in left arm.  Today, 11/13, Left arm is discoloredeschemic and reddened area.
started with chills, aches and tiredness. progressed over the next 4 days to severe chills nausea tiredness fever SOB headache and aches all over body.  Called pharmacy and recommendations for flu given rest and liquids.  Allowed to take NyQuil flu and cold medicine and this did help.  Not fully recovered but able to tolerate somewhat.  Did not want to miss work
Patient is uncertain if she may be pregnant from an encounter in early December.  She missed her last period.   We discussed the pros/cons of mRNA vaccinations and she elected to be vaccinated.    ~15 min after injection, while seated, she reported nausea and lightheadedness.  She was taken to lie down flat. Pale, alert.  HR=60 thready,  RR=20's sweaty, BP 95/58 After 10 min supine, HR=88, RR=20s, BP 132/85 Pallor and malaise resolved. No meds given.  Released and reported well.
Hepatitis A vaccine given to 1month old by mistake by medical assistant. This was explained to the parent, who agreed to get the correct vaccine, Hepatitis B, which was then administered the same day. No adverse reaction noted. Baby was seen again a month later on 1/11/2021 for her 2month well visit & was noted to be doing well with no adverse events.
anxiety/possible panic attack, left arm numbness/tingling, patient encouraged to go to ER for further eval, facility staff took her to ER (next door to facility).
NOT ANAPHYLAXIS. INCREASED SLEEP, SEDATION, DECREASED FEEDING. DID VOMIT BUT HAS REFLUX AS WELL.
VOMITING; DIARRHEA; SLEEPINESS; NAUSEA; LOW GRADE FEVER; SORENESS, ACHY KIND OF LIKE WHEN HAVE THE FLU; A LITTLE BIT OF SWELLING; This spontaneous report received from a patient concerned a 26 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 06-MAY-2021 for prophylactic vaccination. No concomitant medications were reported.  On MAY-2021, the subject experienced soreness, achy kind of like when have the flu. On MAY-2021, the subject experienced a little bit of swelling. On MAY-2021, the subject experienced low grade fever. On 12-MAY-2021, the subject experienced vomiting. On 12-MAY-2021, the subject experienced diarrhea. On 12-MAY-2021, the subject experienced sleepiness. On 12-MAY-2021, the subject experienced nausea. The action taken with covid-19 vaccine  was not applicable. The patient recovered from soreness, achy kind of like when have the flu, a little bit of swelling, vomiting, and low grade fever on MAY-2021, and had not recovered from nausea, diarrhea, and sleepiness. This report was non-serious.
Pronounced heat, swelling and redness at site.  Symptoms continue for more that 72 hours past injection.